BUDAPEST, Hungary, Jan. 26, 2026 /PRNewswire/ — On 19 January 2026, the Korea Trade Commission (KTC) instituted a case based on claims filed by Tulip Innovation that Sunwoda’s lithium-ion battery cells and Geely Auto Group’s battery packs – supplied for a best-selling hybrid SUV in Korea – infringe a patent included in Tulip’s battery licensing program.… Continue reading Tulip Innovation Patent Claims Against Sunwoda Batteries Expand to Include KTC Action
Category: Newswire
CATL and the Ellen Macarthur Foundation Set Direction for Circular EV Batteries with Landmark Whitepaper
DAVOS, Switzerland, Jan. 24, 2026 /PRNewswire/ — Leading The Charge – Turning risk into reward with a circular economy for EV batteries and critical minerals, a whitepaper released by the Ellen MacArthur Foundation during the World Economic Forum Annual Meeting 2026, marks the first integrated, actionable circular value-chain roadmap for EV batteries grounded in real-world industrial practice.… Continue reading CATL and the Ellen Macarthur Foundation Set Direction for Circular EV Batteries with Landmark Whitepaper
From Davos to Maharashtra: Hirschvogel’s Investment Signals Manufacturing Confidence
Company’s ₹750 crore investment in Maharashtra; 1,000 new employment opportunities PUNE, India, Jan. 24, 2026 /PRNewswire/ — Hirschvogel Components India Pvt. Ltd., a German automotive components manufacturing company operating at Sanaswadi, has taken an important decision to make an additional foreign direct investment of ₹750 crore in Maharashtra. Continue Reading From Davos to Maharashtra: Hirschvogel’s… Continue reading From Davos to Maharashtra: Hirschvogel’s Investment Signals Manufacturing Confidence
Haier Shines at Australian Open 2026: Official Partner Elevates the Game with Smart Innovation and Purpose
MELBOURNE, Australia, Jan. 26, 2026 /PRNewswire/ — Haier, the world’s No.1 major home appliance brand, continues its strategic partnership with the Australian Open (AO) in 2026, shining brightly on one of the world’s most prestigious sporting stages. Returning to Melbourne Park, Haier is electrifying the tournament atmosphere, bridging the gap between elite athletic performance and the… Continue reading Haier Shines at Australian Open 2026: Official Partner Elevates the Game with Smart Innovation and Purpose
Haier Shines at Australian Open 2026: Official Partner Elevates the Game with Smart Innovation and Purpose
MELBOURNE, Australia, Jan. 25, 2026 /PRNewswire/ — Haier, the world’s No.1 major home appliance brand, continues its strategic partnership with the Australian Open (AO) in 2026, shining brightly on one of the world’s most prestigious sporting stages. Returning to Melbourne Park, Haier is electrifying the tournament atmosphere, bridging the gap between elite athletic performance and the… Continue reading Haier Shines at Australian Open 2026: Official Partner Elevates the Game with Smart Innovation and Purpose
Leqembi® Iqlik™ (lecanemab-irmb) supplemental Biologics License Application regarding subcutaneous starting dose granted Priority Review by the US FDA
STOCKHOLM, Jan. 26, 2026 /PRNewswire/ — BioArctic AB’s (publ) (STO: BIOA B) partner Eisai announced today that the supplemental Biologics License Application (sBLA) for Leqembi Iqlik subcutaneous autoinjector (SC-AI) as a weekly starting dose has been granted Priority Review by the U.S. Food and Drug Administration (FDA). Leqembi is indicated for the treatment of Alzheimer’s… Continue reading Leqembi® Iqlik™ (lecanemab-irmb) supplemental Biologics License Application regarding subcutaneous starting dose granted Priority Review by the US FDA
Leqembi® Iqlik™ (lecanemab-irmb) supplemental Biologics License Application regarding subcutaneous starting dose granted Priority Review by the US FDA
STOCKHOLM, Jan. 25, 2026 /PRNewswire/ — BioArctic AB’s (publ) (STO: BIOA B) partner Eisai announced today that the supplemental Biologics License Application (sBLA) for Leqembi Iqlik subcutaneous autoinjector (SC-AI) as a weekly starting dose has been granted Priority Review by the U.S. Food and Drug Administration (FDA). Leqembi is indicated for the treatment of Alzheimer’s… Continue reading Leqembi® Iqlik™ (lecanemab-irmb) supplemental Biologics License Application regarding subcutaneous starting dose granted Priority Review by the US FDA
DigiFT Introduces First Actively Managed Tokenized Equity Fund with BNY as Investment Management Services Provider
First actively managed tokenized equity fund extending tokenization beyond single assets to professionally managed public equity strategies Tokenized on Ethereum and distributed via DigiFT, providing eligible investors a regulated on-chain way to invest Advances institutional adoption of tokenization, building on BNY’s deep investment expertise and DigiFT’s track record of bringing Tier-1 asset manager strategies on-chain… Continue reading DigiFT Introduces First Actively Managed Tokenized Equity Fund with BNY as Investment Management Services Provider
Life Time Miami Marathon & Half Delivers an Unforgettable Weekend for More Than 17,000 Runners
‘Magic City’ comes alive for the 24th annual event MIAMI, Jan. 25, 2026 /PRNewswire/ — The 24th Annual Life Time Miami Marathon and Half presented by FP Movement once again transformed South Florida into a vibrant celebration of running, drawing a global community of more than 17,000 athletes from 49 states and 82 countries, making… Continue reading Life Time Miami Marathon & Half Delivers an Unforgettable Weekend for More Than 17,000 Runners
Columbia University Names Jennifer L. Mnookin as Next President
NEW YORK, Jan. 25, 2026 /PRNewswire/ — Columbia University’s Board of Trustees has appointed Jennifer L. Mnookin, a nationally recognized legal scholar who serves as the Chancellor of the University of Wisconsin-Madison, to be the next president of Columbia University, effective July 1, 2026. The appointment concludes an extensive national search led by a committee of… Continue reading Columbia University Names Jennifer L. Mnookin as Next President